128 related articles for article (PubMed ID: 8299527)
1. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
[TBL] [Abstract][Full Text] [Related]
2. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
4. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
[TBL] [Abstract][Full Text] [Related]
5. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
Palla R; Panichi V; Finato V; Parrini M; Andreini B; Bianchi AM; Giovannini L; Migliori M; Bertelli AA
Int J Clin Pharmacol Res; 1994; 14(1):35-43. PubMed ID: 7927959
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy.
Amara AB; Sharma A; Alexander JL; Alfirevic A; Mohiuddin A; Pirmohamed M; Close GL; Grime S; Maltby P; Shawki H; Heyworth S; Shenkin A; Smith L; Sharma AK; Hammad A; Rustom R
Transplantation; 2010 Jan; 89(1):104-14. PubMed ID: 20061926
[TBL] [Abstract][Full Text] [Related]
7. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
Jenkins DA; Cowan P; Patrick AW; Clarke BF
Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
Székács B; Vajo Z; Dachman W
Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
10. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
[TBL] [Abstract][Full Text] [Related]
11. Reduction of proteinuria and changes of renal function in patients with glomerulonephritis and mild renal insufficiency. Short- versus long-acting angiotensin-converting enzyme inhibitors.
Erley CM; Wolf S; Komini E; Nicaeus T; Braun N; Risler T
Contrib Nephrol; 1994; 106():68-73. PubMed ID: 8174380
[No Abstract] [Full Text] [Related]
12. [The effect of captopril on proteinuria in glomerular diseases].
Yamaguchi Y; Saito T; Obara K; Ootaka T; Akiu N; Sato H; Kinoshita Y; Seino J; Tsunoda K; Yasujima M
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1009-16. PubMed ID: 2263022
[TBL] [Abstract][Full Text] [Related]
13. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
Gosse P; Dallocchio M; Gourgon R
J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
[TBL] [Abstract][Full Text] [Related]
16. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
Boratyńska M; Mazanowska O; Szewczyk Z; Czyz W
Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1090-2. PubMed ID: 1305732
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
Risler T; Braun U; Klärner HG; Müller-Schauenburg W; Heitkamp HC; Brilla GG; Krämer BK; Seipel L
Z Kardiol; 1991; 80 Suppl 2():40-3. PubMed ID: 1850942
[TBL] [Abstract][Full Text] [Related]
20. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
